A primary goal of precision medicine is to identify patient subgroups and infer their underlying disease processes to design interventions that are targeted to those processes. However, few approaches to identify patient subgroups are designed to reveal relationships within and across patient subgroups, which constrains the ability of clinician and patient stakeholders to fully comprehend the processes underlying heterogeneity in a patient population.
